Michelle L. Miller, Ph.D. - Publications

Affiliations: 
Committee on the Neurobiology of Addictive Disorders Scripps Research Institute, La Jolla, La Jolla, CA, United States 

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Miller ML, Aarde SM, Moreno AY, Creehan KM, Janda KD, Taffe MA. Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats. Drug and Alcohol Dependence. PMID 26118833 DOI: 10.1016/j.drugalcdep.2015.06.014  1
2015 Aarde SM, Miller ML, Creehan KM, Vandewater SA, Taffe MA. One day access to a running wheel reduces self-administration of d-methamphetamine, MDMA and methylone. Drug and Alcohol Dependence. 151: 151-8. PMID 25863714 DOI: 10.1016/j.drugalcdep.2015.03.016  1
2013 Lin H, Miller ML, Granas DM, Dutcher SK. Whole genome sequencing identifies a deletion in protein phosphatase 2A that affects its stability and localization in Chlamydomonas reinhardtii. Plos Genetics. 9: e1003841. PMID 24086163 DOI: 10.1371/journal.pgen.1003841  1
2013 Miller ML, Moreno AY, Aarde SM, Creehan KM, Vandewater SA, Vaillancourt BD, Wright MJ, Janda KD, Taffe MA. A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats. Biological Psychiatry. 73: 721-8. PMID 23098894 DOI: 10.1016/j.biopsych.2012.09.010  1
2013 Miller ML, Creehan KM, Angrish D, Barlow DJ, Houseknecht KL, Dickerson TJ, Taffe MA. Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone). Drug and Alcohol Dependence. 127: 248-53. PMID 22832282 DOI: 10.1016/j.drugalcdep.2012.07.003  1
2012 Miller ML, Vaillancourt BD, Wright MJ, Aarde SM, Vandewater SA, Creehan KM, Taffe MA. Reciprocal inhibitory effects of intravenous d-methamphetamine self-administration and wheel activity in rats. Drug and Alcohol Dependence. 121: 90-6. PMID 21899959 DOI: 10.1016/j.drugalcdep.2011.08.013  1
2011 Crunelle CL, Schulz S, de Bruin K, Miller ML, van den Brink W, Booij J. Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 21: 205-10. PMID 21130610 DOI: 10.1016/j.euroneuro.2010.11.001  1
2010 Crunelle CL, Miller ML, Booij J, van den Brink W. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 69-79. PMID 19959340 DOI: 10.1016/j.euroneuro.2009.11.001  1
2009 Crunelle CL, Miller ML, de Bruin K, van den Brink W, Booij J. Varenicline increases striatal dopamine D(2/3) receptor binding in rats. Addiction Biology. 14: 500-2. PMID 19650815 DOI: 10.1111/j.1369-1600.2009.00168.x  1
2009 Bazán C, Miller M, Blomgren P. Structure enhancement diffusion and contour extraction for electron tomography of mitochondria Journal of Structural Biology. 166: 144-155. PMID 19254765 DOI: 10.1016/j.jsb.2009.02.009  1
2007 Bickel WK, Miller ML, Yi R, Kowal BP, Lindquist DM, Pitcock JA. Behavioral and neuroeconomics of drug addiction: competing neural systems and temporal discounting processes. Drug and Alcohol Dependence. 90: S85-91. PMID 17101239 DOI: 10.1016/j.drugalcdep.2006.09.016  1
2004 Miller ML, Branch MN. Tolerance to response-disruptive effects of cocaine is facilitated by opportunity to respond in the absence of drug. Pharmacology, Biochemistry, and Behavior. 79: 43-54. PMID 15388283 DOI: 10.1016/j.pbb.2004.06.013  1
2004 Miller ML, Fee VE, Netterville AK. Psychometric properties of ADHD rating scales among children with mental retardation I: reliability. Research in Developmental Disabilities. 25: 459-76. PMID 15217674 DOI: 10.1016/j.ridd.2003.11.003  0.28
2003 Richards JL, Abend JR, Miller ML, Chakraborty-Sett S, Dewhurst S, Whetter LE. A peptide containing a novel FPGN CD40-binding sequence enhances adenoviral infection of murine and human dendritic cells. European Journal of Biochemistry / Febs. 270: 2287-94. PMID 12752448 DOI: 10.1046/j.1432-1033.2003.03596.x  1
2003 Richards J, Miller M, Abend J, Koide A, Koide S, Dewhurst S. Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin. Journal of Molecular Biology. 326: 1475-88. PMID 12595259 DOI: 10.1016/S0022-2836(03)00082-2  1
2002 Miller ML, Branch MN. Role of dose order in the development of tolerance to effects of cocaine on schedule-controlled behavior in pigeons. Psychopharmacology. 163: 302-9. PMID 12373431 DOI: 10.1007/s00213-002-1085-3  1
2001 Miller ML, Brodkorb GW, Branch MN. Tolerance to the effects of cocaine on performance under behavior-correlated reinforcement magnitude. Journal of the Experimental Analysis of Behavior. 76: 217-34. PMID 11599640 DOI: 10.1901/jeab.2001.76-217  1
1997 Carroll SL, Miller ML, Frohnert PW, Kim SS, Corbett JA. Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 1642-59. PMID 9030624  1
1995 Carroll SL, Schweitzer JB, Holtzman DM, Miller ML, Sclar GM, Milbrandt J. Elements in the 5' flanking sequences of the mouse low-affinity NGF receptor gene direct appropriate CNS, but not PNS, expression in transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 3342-56. PMID 7751914  1
1994 Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetologica. 31: 215-9. PMID 7888692 DOI: 10.1007/BF00571954  1
1992 Miller M, Hamilton M, Flaherty B. The evaluation of Australia's national campaign against drug abuse Journal of Drug Issues. 22: 487-506. DOI: 10.1177/002204269202200303  1
Show low-probability matches.